CALCIMEDICA INC (CALC) Stock Analyst Earnings Estimates
NASDAQ:CALC - Nasdaq - US38942Q2021 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||||||
| EBITDA YoY % growth | -28.39M | -37.2M -31.03% | -29.43M 20.89% | -35.43M -20.39% | -32.88M 7.20% | -38.017M -15.62% | N/A 32.39% | N/A -13.89% | N/A -22.30% | |
| EBIT YoY % growth | -28.57M | -37.5M -31.26% | -29.83M 20.45% | -35.95M -20.52% | -33.22M 7.59% | -38.075M -14.61% | N/A 35.53% | N/A -18.70% | N/A -10.44% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -7.02 87.66% | N/A 74.57% | -25.59 -1,333.61% | N/A 95.08% | N/A -15.41% | N/A 12.18% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 -44.87% | -0.79 -7,954.00% | 3.81 1,159.67% | -0.93 -85.64% | -1.07 -221.43% |
| Revenue Q2Q % growth | 51M | ||||
| EBITDA Q2Q % growth | -7.242M -69.96% | -8.772M -52.50% | 41.208M 733.97% | -10.302M -80.99% | -11.832M -63.38% |
| EBIT Q2Q % growth | -5.61M -29.89% | -8.772M -52.11% | 41.208M 731.15% | -10.302M -79.60% | -11.832M -110.91% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.50 39.02% | -0.51 | 0.01 | 1.30% |
| Q2 2024 Q2Q % growth | -0.36 67.57% | -0.54 | 0.18 | 32.99% |
| Q1 2024 Q2Q % growth | 0.01 100.04% | -0.68 | 0.69 | 101.47% |
| Q4 2023 Q2Q % growth | -0.23 49.89% | -0.89 | 0.66 | 74.16% |
| Q3 2023 Q2Q % growth | -0.82 87.27% | -1.16 | 0.34 | 29.48% |
| Q2 2023 Q2Q % growth | -1.11 79.14% | -1.07 | -0.04 | -4.14% |
| Q1 2023 Q2Q % growth | -23.43 -248.66% | -0.74 | -22.69 | -3,046.66% |
| Q4 2022 Q2Q % growth | 92.00% | -0.46 | % | |
| Q3 2022 Q2Q % growth | -6.44 -1,594.74% | -6.28 | -0.16 | -2.50% |
| Q2 2022 Q2Q % growth | -5.32 -1,377.78% | -5.74 | 0.42 | 7.33% |
| Q1 2022 Q2Q % growth | -6.72 -1,144.44% | -5.46 | -1.26 | -23.06% |
| Q4 2021 Q2Q % growth | -5.74 -315.94% | -5.23 | -0.51 | -9.83% |
| Q3 2021 Q2Q % growth | -0.38 84.92% | -0.38 | 0.00 | -0.69% |
| Q2 2021 Q2Q % growth | -0.36 | -0.48 | 0.12 | 24.59% |
| Q1 2021 Q2Q % growth | -0.54 | -0.45 | -0.09 | -20.32% |
| Q4 2020 Q2Q % growth | -1.38 | -0.41 | -0.97 | -234.06% |
| Q3 2020 Q2Q % growth | -2.52 | -0.57 | -1.95 | -341.18% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | 76.5K | -76.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.51% | -0.51% | -3.21% | 0.27% |
| Revenue | N/A | N/A | N/A | N/A |